ViGenCell Inc. (KOSDAQ:308080)

South Korea · Delayed Price · Currency is KRW

10,000

+500 (5.26%)

At close: Jun 8, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024
Period Ending	Dec '24 Dec 31, 2024
Medical Labs & Research	278.95M
Total	278.95M

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024
Period Ending	Dec '24 Dec 31, 2024
South Korea	278.95M
Total	278.95M

Source: S&P Global Market Intelligence.